Profil
Lisa V.
Sellers currently works at Vector Laboratories, Inc., as Chief Executive Officer from 2021.
Dr. Sellers also formerly worked at 10X Genomics, Inc., as Vice President-Marketing and Maravai Lifesciences Holdings, Inc., as Chief Operating Officer-Protein Detection.
Dr. Sellers received her undergraduate degree from Santa Clara University and doctorate degree from the University of Colorado Boulder.
Postes actifs de Lisa V. Sellers
| Sociétés | Poste | Début |
|---|---|---|
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures and supplies labelling and detection reagents to the scientific community | Directeur Général | 07/09/2021 |
Anciens postes connus de Lisa V. Sellers
| Sociétés | Poste | Fin |
|---|---|---|
| 10X GENOMICS, INC. | Sales & Marketing | - |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Corporate Officer/Principal | - |
Formation de Lisa V. Sellers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
10X Genomics, Inc.
10X Genomics, Inc. BiotechnologyHealth Technology Develops integrated systems and solutions for genome sequencing, exome sequencing and single cell transcriptomics | Health Technology |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures and supplies labelling and detection reagents to the scientific community | Process Industries |
University of Colorado Boulder
University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maravai Lifesciences Holdings, Inc.
Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
















